Global Multiple Sclerosis Therapeutics Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 89

Published Date: 07 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problems between your brain and the rest of your body. Eventually, the disease can cause the nerves themselves to deteriorate or become permanently damaged.

According to our (Global Info Research) latest study, the global Multiple Sclerosis Therapeutics market size was valued at USD 17530 million in 2022 and is forecast to a readjusted size of USD 20010 million by 2029 with a CAGR of 1.9% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Multiple Sclerosis Therapeutics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Distribution Channel. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Multiple Sclerosis Therapeutics market size and forecasts, in consumption value ($ Million), 2018-2029
Global Multiple Sclerosis Therapeutics market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Multiple Sclerosis Therapeutics market size and forecasts, by Type and by Distribution Channel, in consumption value ($ Million), 2018-2029
Global Multiple Sclerosis Therapeutics market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Multiple Sclerosis Therapeutics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Multiple Sclerosis Therapeutics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Teva Pharmaceuticals, Sanofi Genzyme, Bayer and Pfizer, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Multiple Sclerosis Therapeutics market is split by Type and by Distribution Channel. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Distribution Channel. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Beta Interferon
    Corticosteroids
    Monoclonal Antibodies
    Antineoplastic Agents
    Others

Market segment by Distribution Channel
    Hospital Pharmacies
    Retail Pharmacies
    e-Commerce

Market segment by players, this report covers
    Novartis
    Teva Pharmaceuticals
    Sanofi Genzyme
    Bayer
    Pfizer
    Biogen Idec
    Merck
    AbbVie

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Multiple Sclerosis Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Multiple Sclerosis Therapeutics, with revenue, gross margin and global market share of Multiple Sclerosis Therapeutics from 2018 to 2023.
Chapter 3, the Multiple Sclerosis Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Multiple Sclerosis Therapeutics market forecast, by regions, type and distribution channel, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Multiple Sclerosis Therapeutics.
Chapter 13, to describe Multiple Sclerosis Therapeutics research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Multiple Sclerosis Therapeutics
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Multiple Sclerosis Therapeutics by Type
        1.3.1 Overview: Global Multiple Sclerosis Therapeutics Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Multiple Sclerosis Therapeutics Consumption Value Market Share by Type in 2022
        1.3.3 Beta Interferon
        1.3.4 Corticosteroids
        1.3.5 Monoclonal Antibodies
        1.3.6 Antineoplastic Agents
        1.3.7 Others
    1.4 Global Multiple Sclerosis Therapeutics Market by Distribution Channel
        1.4.1 Overview: Global Multiple Sclerosis Therapeutics Market Size by Distribution Channel: 2018 Versus 2022 Versus 2029
        1.4.2 Hospital Pharmacies
        1.4.3 Retail Pharmacies
        1.4.4 e-Commerce
    1.5 Global Multiple Sclerosis Therapeutics Market Size & Forecast
    1.6 Global Multiple Sclerosis Therapeutics Market Size and Forecast by Region
        1.6.1 Global Multiple Sclerosis Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Multiple Sclerosis Therapeutics Market Size by Region, (2018-2029)
        1.6.3 North America Multiple Sclerosis Therapeutics Market Size and Prospect (2018-2029)
        1.6.4 Europe Multiple Sclerosis Therapeutics Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Multiple Sclerosis Therapeutics Market Size and Prospect (2018-2029)
        1.6.6 South America Multiple Sclerosis Therapeutics Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Multiple Sclerosis Therapeutics Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Novartis
        2.1.1 Novartis Details
        2.1.2 Novartis Major Business
        2.1.3 Novartis Multiple Sclerosis Therapeutics Product and Solutions
        2.1.4 Novartis Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Novartis Recent Developments and Future Plans
    2.2 Teva Pharmaceuticals
        2.2.1 Teva Pharmaceuticals Details
        2.2.2 Teva Pharmaceuticals Major Business
        2.2.3 Teva Pharmaceuticals Multiple Sclerosis Therapeutics Product and Solutions
        2.2.4 Teva Pharmaceuticals Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Teva Pharmaceuticals Recent Developments and Future Plans
    2.3 Sanofi Genzyme
        2.3.1 Sanofi Genzyme Details
        2.3.2 Sanofi Genzyme Major Business
        2.3.3 Sanofi Genzyme Multiple Sclerosis Therapeutics Product and Solutions
        2.3.4 Sanofi Genzyme Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Sanofi Genzyme Recent Developments and Future Plans
    2.4 Bayer
        2.4.1 Bayer Details
        2.4.2 Bayer Major Business
        2.4.3 Bayer Multiple Sclerosis Therapeutics Product and Solutions
        2.4.4 Bayer Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Bayer Recent Developments and Future Plans
    2.5 Pfizer
        2.5.1 Pfizer Details
        2.5.2 Pfizer Major Business
        2.5.3 Pfizer Multiple Sclerosis Therapeutics Product and Solutions
        2.5.4 Pfizer Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Pfizer Recent Developments and Future Plans
    2.6 Biogen Idec
        2.6.1 Biogen Idec Details
        2.6.2 Biogen Idec Major Business
        2.6.3 Biogen Idec Multiple Sclerosis Therapeutics Product and Solutions
        2.6.4 Biogen Idec Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Biogen Idec Recent Developments and Future Plans
    2.7 Merck
        2.7.1 Merck Details
        2.7.2 Merck Major Business
        2.7.3 Merck Multiple Sclerosis Therapeutics Product and Solutions
        2.7.4 Merck Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Merck Recent Developments and Future Plans
    2.8 AbbVie
        2.8.1 AbbVie Details
        2.8.2 AbbVie Major Business
        2.8.3 AbbVie Multiple Sclerosis Therapeutics Product and Solutions
        2.8.4 AbbVie Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 AbbVie Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Multiple Sclerosis Therapeutics Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Multiple Sclerosis Therapeutics by Company Revenue
        3.2.2 Top 3 Multiple Sclerosis Therapeutics Players Market Share in 2022
        3.2.3 Top 6 Multiple Sclerosis Therapeutics Players Market Share in 2022
    3.3 Multiple Sclerosis Therapeutics Market: Overall Company Footprint Analysis
        3.3.1 Multiple Sclerosis Therapeutics Market: Region Footprint
        3.3.2 Multiple Sclerosis Therapeutics Market: Company Product Type Footprint
        3.3.3 Multiple Sclerosis Therapeutics Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Multiple Sclerosis Therapeutics Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Multiple Sclerosis Therapeutics Market Forecast by Type (2024-2029)

5 Market Size Segment by Distribution Channel
    5.1 Global Multiple Sclerosis Therapeutics Consumption Value Market Share by Distribution Channel (2018-2023)
    5.2 Global Multiple Sclerosis Therapeutics Market Forecast by Distribution Channel (2024-2029)

6 North America
    6.1 North America Multiple Sclerosis Therapeutics Consumption Value by Type (2018-2029)
    6.2 North America Multiple Sclerosis Therapeutics Consumption Value by Distribution Channel (2018-2029)
    6.3 North America Multiple Sclerosis Therapeutics Market Size by Country
        6.3.1 North America Multiple Sclerosis Therapeutics Consumption Value by Country (2018-2029)
        6.3.2 United States Multiple Sclerosis Therapeutics Market Size and Forecast (2018-2029)
        6.3.3 Canada Multiple Sclerosis Therapeutics Market Size and Forecast (2018-2029)
        6.3.4 Mexico Multiple Sclerosis Therapeutics Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Multiple Sclerosis Therapeutics Consumption Value by Type (2018-2029)
    7.2 Europe Multiple Sclerosis Therapeutics Consumption Value by Distribution Channel (2018-2029)
    7.3 Europe Multiple Sclerosis Therapeutics Market Size by Country
        7.3.1 Europe Multiple Sclerosis Therapeutics Consumption Value by Country (2018-2029)
        7.3.2 Germany Multiple Sclerosis Therapeutics Market Size and Forecast (2018-2029)
        7.3.3 France Multiple Sclerosis Therapeutics Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Multiple Sclerosis Therapeutics Market Size and Forecast (2018-2029)
        7.3.5 Russia Multiple Sclerosis Therapeutics Market Size and Forecast (2018-2029)
        7.3.6 Italy Multiple Sclerosis Therapeutics Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Multiple Sclerosis Therapeutics Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Multiple Sclerosis Therapeutics Consumption Value by Distribution Channel (2018-2029)
    8.3 Asia-Pacific Multiple Sclerosis Therapeutics Market Size by Region
        8.3.1 Asia-Pacific Multiple Sclerosis Therapeutics Consumption Value by Region (2018-2029)
        8.3.2 China Multiple Sclerosis Therapeutics Market Size and Forecast (2018-2029)
        8.3.3 Japan Multiple Sclerosis Therapeutics Market Size and Forecast (2018-2029)
        8.3.4 South Korea Multiple Sclerosis Therapeutics Market Size and Forecast (2018-2029)
        8.3.5 India Multiple Sclerosis Therapeutics Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Multiple Sclerosis Therapeutics Market Size and Forecast (2018-2029)
        8.3.7 Australia Multiple Sclerosis Therapeutics Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Multiple Sclerosis Therapeutics Consumption Value by Type (2018-2029)
    9.2 South America Multiple Sclerosis Therapeutics Consumption Value by Distribution Channel (2018-2029)
    9.3 South America Multiple Sclerosis Therapeutics Market Size by Country
        9.3.1 South America Multiple Sclerosis Therapeutics Consumption Value by Country (2018-2029)
        9.3.2 Brazil Multiple Sclerosis Therapeutics Market Size and Forecast (2018-2029)
        9.3.3 Argentina Multiple Sclerosis Therapeutics Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Multiple Sclerosis Therapeutics Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Multiple Sclerosis Therapeutics Consumption Value by Distribution Channel (2018-2029)
    10.3 Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Country
        10.3.1 Middle East & Africa Multiple Sclerosis Therapeutics Consumption Value by Country (2018-2029)
        10.3.2 Turkey Multiple Sclerosis Therapeutics Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Multiple Sclerosis Therapeutics Market Size and Forecast (2018-2029)
        10.3.4 UAE Multiple Sclerosis Therapeutics Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Multiple Sclerosis Therapeutics Market Drivers
    11.2 Multiple Sclerosis Therapeutics Market Restraints
    11.3 Multiple Sclerosis Therapeutics Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Multiple Sclerosis Therapeutics Industry Chain
    12.2 Multiple Sclerosis Therapeutics Upstream Analysis
    12.3 Multiple Sclerosis Therapeutics Midstream Analysis
    12.4 Multiple Sclerosis Therapeutics Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Multiple Sclerosis Therapeutics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Multiple Sclerosis Therapeutics Consumption Value by Distribution Channel, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Multiple Sclerosis Therapeutics Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Multiple Sclerosis Therapeutics Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Novartis Company Information, Head Office, and Major Competitors
    Table 6. Novartis Major Business
    Table 7. Novartis Multiple Sclerosis Therapeutics Product and Solutions
    Table 8. Novartis Multiple Sclerosis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Novartis Recent Developments and Future Plans
    Table 10. Teva Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 11. Teva Pharmaceuticals Major Business
    Table 12. Teva Pharmaceuticals Multiple Sclerosis Therapeutics Product and Solutions
    Table 13. Teva Pharmaceuticals Multiple Sclerosis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Teva Pharmaceuticals Recent Developments and Future Plans
    Table 15. Sanofi Genzyme Company Information, Head Office, and Major Competitors
    Table 16. Sanofi Genzyme Major Business
    Table 17. Sanofi Genzyme Multiple Sclerosis Therapeutics Product and Solutions
    Table 18. Sanofi Genzyme Multiple Sclerosis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Sanofi Genzyme Recent Developments and Future Plans
    Table 20. Bayer Company Information, Head Office, and Major Competitors
    Table 21. Bayer Major Business
    Table 22. Bayer Multiple Sclerosis Therapeutics Product and Solutions
    Table 23. Bayer Multiple Sclerosis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Bayer Recent Developments and Future Plans
    Table 25. Pfizer Company Information, Head Office, and Major Competitors
    Table 26. Pfizer Major Business
    Table 27. Pfizer Multiple Sclerosis Therapeutics Product and Solutions
    Table 28. Pfizer Multiple Sclerosis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Pfizer Recent Developments and Future Plans
    Table 30. Biogen Idec Company Information, Head Office, and Major Competitors
    Table 31. Biogen Idec Major Business
    Table 32. Biogen Idec Multiple Sclerosis Therapeutics Product and Solutions
    Table 33. Biogen Idec Multiple Sclerosis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Biogen Idec Recent Developments and Future Plans
    Table 35. Merck Company Information, Head Office, and Major Competitors
    Table 36. Merck Major Business
    Table 37. Merck Multiple Sclerosis Therapeutics Product and Solutions
    Table 38. Merck Multiple Sclerosis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Merck Recent Developments and Future Plans
    Table 40. AbbVie Company Information, Head Office, and Major Competitors
    Table 41. AbbVie Major Business
    Table 42. AbbVie Multiple Sclerosis Therapeutics Product and Solutions
    Table 43. AbbVie Multiple Sclerosis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. AbbVie Recent Developments and Future Plans
    Table 45. Global Multiple Sclerosis Therapeutics Revenue (USD Million) by Players (2018-2023)
    Table 46. Global Multiple Sclerosis Therapeutics Revenue Share by Players (2018-2023)
    Table 47. Breakdown of Multiple Sclerosis Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 48. Market Position of Players in Multiple Sclerosis Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 49. Head Office of Key Multiple Sclerosis Therapeutics Players
    Table 50. Multiple Sclerosis Therapeutics Market: Company Product Type Footprint
    Table 51. Multiple Sclerosis Therapeutics Market: Company Product Application Footprint
    Table 52. Multiple Sclerosis Therapeutics New Market Entrants and Barriers to Market Entry
    Table 53. Multiple Sclerosis Therapeutics Mergers, Acquisition, Agreements, and Collaborations
    Table 54. Global Multiple Sclerosis Therapeutics Consumption Value (USD Million) by Type (2018-2023)
    Table 55. Global Multiple Sclerosis Therapeutics Consumption Value Share by Type (2018-2023)
    Table 56. Global Multiple Sclerosis Therapeutics Consumption Value Forecast by Type (2024-2029)
    Table 57. Global Multiple Sclerosis Therapeutics Consumption Value by Distribution Channel (2018-2023)
    Table 58. Global Multiple Sclerosis Therapeutics Consumption Value Forecast by Distribution Channel (2024-2029)
    Table 59. North America Multiple Sclerosis Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
    Table 60. North America Multiple Sclerosis Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
    Table 61. North America Multiple Sclerosis Therapeutics Consumption Value by Distribution Channel (2018-2023) & (USD Million)
    Table 62. North America Multiple Sclerosis Therapeutics Consumption Value by Distribution Channel (2024-2029) & (USD Million)
    Table 63. North America Multiple Sclerosis Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
    Table 64. North America Multiple Sclerosis Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
    Table 65. Europe Multiple Sclerosis Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
    Table 66. Europe Multiple Sclerosis Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
    Table 67. Europe Multiple Sclerosis Therapeutics Consumption Value by Distribution Channel (2018-2023) & (USD Million)
    Table 68. Europe Multiple Sclerosis Therapeutics Consumption Value by Distribution Channel (2024-2029) & (USD Million)
    Table 69. Europe Multiple Sclerosis Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
    Table 70. Europe Multiple Sclerosis Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
    Table 71. Asia-Pacific Multiple Sclerosis Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
    Table 72. Asia-Pacific Multiple Sclerosis Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
    Table 73. Asia-Pacific Multiple Sclerosis Therapeutics Consumption Value by Distribution Channel (2018-2023) & (USD Million)
    Table 74. Asia-Pacific Multiple Sclerosis Therapeutics Consumption Value by Distribution Channel (2024-2029) & (USD Million)
    Table 75. Asia-Pacific Multiple Sclerosis Therapeutics Consumption Value by Region (2018-2023) & (USD Million)
    Table 76. Asia-Pacific Multiple Sclerosis Therapeutics Consumption Value by Region (2024-2029) & (USD Million)
    Table 77. South America Multiple Sclerosis Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
    Table 78. South America Multiple Sclerosis Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
    Table 79. South America Multiple Sclerosis Therapeutics Consumption Value by Distribution Channel (2018-2023) & (USD Million)
    Table 80. South America Multiple Sclerosis Therapeutics Consumption Value by Distribution Channel (2024-2029) & (USD Million)
    Table 81. South America Multiple Sclerosis Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
    Table 82. South America Multiple Sclerosis Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
    Table 83. Middle East & Africa Multiple Sclerosis Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
    Table 84. Middle East & Africa Multiple Sclerosis Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
    Table 85. Middle East & Africa Multiple Sclerosis Therapeutics Consumption Value by Distribution Channel (2018-2023) & (USD Million)
    Table 86. Middle East & Africa Multiple Sclerosis Therapeutics Consumption Value by Distribution Channel (2024-2029) & (USD Million)
    Table 87. Middle East & Africa Multiple Sclerosis Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
    Table 88. Middle East & Africa Multiple Sclerosis Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
    Table 89. Multiple Sclerosis Therapeutics Raw Material
    Table 90. Key Suppliers of Multiple Sclerosis Therapeutics Raw Materials
List of Figures
    Figure 1. Multiple Sclerosis Therapeutics Picture
    Figure 2. Global Multiple Sclerosis Therapeutics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Multiple Sclerosis Therapeutics Consumption Value Market Share by Type in 2022
    Figure 4. Beta Interferon
    Figure 5. Corticosteroids
    Figure 6. Monoclonal Antibodies
    Figure 7. Antineoplastic Agents
    Figure 8. Others
    Figure 9. Global Multiple Sclerosis Therapeutics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 10. Multiple Sclerosis Therapeutics Consumption Value Market Share by Distribution Channel in 2022
    Figure 11. Hospital Pharmacies Picture
    Figure 12. Retail Pharmacies Picture
    Figure 13. e-Commerce Picture
    Figure 14. Global Multiple Sclerosis Therapeutics Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 15. Global Multiple Sclerosis Therapeutics Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 16. Global Market Multiple Sclerosis Therapeutics Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 17. Global Multiple Sclerosis Therapeutics Consumption Value Market Share by Region (2018-2029)
    Figure 18. Global Multiple Sclerosis Therapeutics Consumption Value Market Share by Region in 2022
    Figure 19. North America Multiple Sclerosis Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 20. Europe Multiple Sclerosis Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 21. Asia-Pacific Multiple Sclerosis Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 22. South America Multiple Sclerosis Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 23. Middle East and Africa Multiple Sclerosis Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 24. Global Multiple Sclerosis Therapeutics Revenue Share by Players in 2022
    Figure 25. Multiple Sclerosis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 26. Global Top 3 Players Multiple Sclerosis Therapeutics Market Share in 2022
    Figure 27. Global Top 6 Players Multiple Sclerosis Therapeutics Market Share in 2022
    Figure 28. Global Multiple Sclerosis Therapeutics Consumption Value Share by Type (2018-2023)
    Figure 29. Global Multiple Sclerosis Therapeutics Market Share Forecast by Type (2024-2029)
    Figure 30. Global Multiple Sclerosis Therapeutics Consumption Value Share by Distribution Channel (2018-2023)
    Figure 31. Global Multiple Sclerosis Therapeutics Market Share Forecast by Distribution Channel (2024-2029)
    Figure 32. North America Multiple Sclerosis Therapeutics Consumption Value Market Share by Type (2018-2029)
    Figure 33. North America Multiple Sclerosis Therapeutics Consumption Value Market Share by Distribution Channel (2018-2029)
    Figure 34. North America Multiple Sclerosis Therapeutics Consumption Value Market Share by Country (2018-2029)
    Figure 35. United States Multiple Sclerosis Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 36. Canada Multiple Sclerosis Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 37. Mexico Multiple Sclerosis Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 38. Europe Multiple Sclerosis Therapeutics Consumption Value Market Share by Type (2018-2029)
    Figure 39. Europe Multiple Sclerosis Therapeutics Consumption Value Market Share by Distribution Channel (2018-2029)
    Figure 40. Europe Multiple Sclerosis Therapeutics Consumption Value Market Share by Country (2018-2029)
    Figure 41. Germany Multiple Sclerosis Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 42. France Multiple Sclerosis Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 43. United Kingdom Multiple Sclerosis Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 44. Russia Multiple Sclerosis Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 45. Italy Multiple Sclerosis Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 46. Asia-Pacific Multiple Sclerosis Therapeutics Consumption Value Market Share by Type (2018-2029)
    Figure 47. Asia-Pacific Multiple Sclerosis Therapeutics Consumption Value Market Share by Distribution Channel (2018-2029)
    Figure 48. Asia-Pacific Multiple Sclerosis Therapeutics Consumption Value Market Share by Region (2018-2029)
    Figure 49. China Multiple Sclerosis Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 50. Japan Multiple Sclerosis Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 51. South Korea Multiple Sclerosis Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 52. India Multiple Sclerosis Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 53. Southeast Asia Multiple Sclerosis Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 54. Australia Multiple Sclerosis Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 55. South America Multiple Sclerosis Therapeutics Consumption Value Market Share by Type (2018-2029)
    Figure 56. South America Multiple Sclerosis Therapeutics Consumption Value Market Share by Distribution Channel (2018-2029)
    Figure 57. South America Multiple Sclerosis Therapeutics Consumption Value Market Share by Country (2018-2029)
    Figure 58. Brazil Multiple Sclerosis Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 59. Argentina Multiple Sclerosis Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 60. Middle East and Africa Multiple Sclerosis Therapeutics Consumption Value Market Share by Type (2018-2029)
    Figure 61. Middle East and Africa Multiple Sclerosis Therapeutics Consumption Value Market Share by Distribution Channel (2018-2029)
    Figure 62. Middle East and Africa Multiple Sclerosis Therapeutics Consumption Value Market Share by Country (2018-2029)
    Figure 63. Turkey Multiple Sclerosis Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 64. Saudi Arabia Multiple Sclerosis Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 65. UAE Multiple Sclerosis Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 66. Multiple Sclerosis Therapeutics Market Drivers
    Figure 67. Multiple Sclerosis Therapeutics Market Restraints
    Figure 68. Multiple Sclerosis Therapeutics Market Trends
    Figure 69. Porters Five Forces Analysis
    Figure 70. Manufacturing Cost Structure Analysis of Multiple Sclerosis Therapeutics in 2022
    Figure 71. Manufacturing Process Analysis of Multiple Sclerosis Therapeutics
    Figure 72. Multiple Sclerosis Therapeutics Industrial Chain
    Figure 73. Methodology
    Figure 74. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Novartis
Teva Pharmaceuticals
Sanofi Genzyme
Bayer
Pfizer
Biogen Idec
Merck
AbbVie

Related Reports

Global Multiple Sclerosis Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global Multiple Sclerosis Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

date 02 Jul 2021

date Pharma & Healthcare

The Multiple Sclerosis Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Multiple Sclerosis Therapeutics Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Multiple Sclerosis Therapeutics Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 08 Jan 2022

date Pharma & Healthcare

Global Multiple Sclerosis Therapeutics Supply, Demand and Key Producers, 2023-2029

Global Multiple Sclerosis Therapeutics Supply, Demand and Key Producers, 2023-2029

date 11 Feb 2023

date Pharma & Healthcare

Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problems between your brain and the rest of your body. Eventually, the disease can cause the nerves themselves to deteriorate or become permanently damaged.

Global Multiple Sclerosis Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Multiple Sclerosis Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Multiple Sclerosis Therapeutics market size was valued at USD 17530 million in 2023 and is forecast to a readjusted size of USD 20010 million by 2030 with a CAGR of 1.9% during review period.

Product Tags

multiple sclerosis therapeutics

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>